Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"The U.S. government does not review or approve the safety and science of all studies listed on this website."
Developments
During 2022 and 2023, the Company worked to address certain deficiencies in its Premarket Approval (PMA) application that were identified by the FDA in 2021. These were largely related to the need for standardized procedures for our manufacturing process, and quality assurance procedures for finished, customer ready products. As of the date of this report we have implemented procedures and Good Manufacturing Practices that are responsive to the deficiencies identified by the FDA.
On March 21, 2024, we submitted to the FDA a revised Premarket Approval application to market our absorbable hemostatic gauze for human surgical applications in the United States. The FDA is currently reviewing our application and there can be no assurance that our PMA application will be approved.
Our HemoStyp Gauze Products
HemoStyp hemostatic gauze is a natural substance created from chemically treated cellulose derived from cotton. It is an effective hemostatic agent registered with the FDA for superficial use under a 510(k) approval obtained in 2012 to help control bleeding from open wounds and body cavities. The HemoStyp hemostatic material contains no chemical additives, thrombin, collagen or animal-derived products, and is hypoallergenic. When the product comes in contact with blood it expands slightly and quickly converts to a translucent gel that subsequently breaks down into glucose and salts. Because of its benign impact on body tissue and the fact that it degrades to non-toxic end products, HemoStyp does not impede the healing of body tissue as compared to certain competing hemostatic products. Laboratory testing has shown HemoStyp to be 100% absorbable in the human body within 24 hours, compared to days or weeks with competing organic regenerated cellulose products. A human trial conducted in 2019 and 2020 demonstrated the effectiveness of HemoStyp in vascular, thoracic and abdominal surgical procedures.
HemoStyp hemostatic gauze is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The supple material can be easily folded and manipulated as needed to fit the size of the wound or incision. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the physician or surgeon to monitor the coagulation process. The gel maintains a neutral pH level, which avoids damaging the surrounding tissue. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a broad range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis.
Still waiting for clinical submission link...and waiting....
I have the feeling I will be waiting forever just like the wait for explanation of why all the past PMA's failed....
I have linked to that 10-K in numerous posts today. It answers none of the questions I have asked. It merely creates more questions I am asking. There is nothing about clinical trials or any explanation of 7 years worth of failed PMA's.
Let me return the favor. Here is a link that actually explains what is going on:
https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf
I post facts with links. Where's your link?
Hey MORON, we have a full clinical submission on 3/20/24. You post nothing but BullShit!
What has happened with UHP PMA's since 2017? Although we never hear about it, the reality of the situation is every time a PMA gets filed from United Con Artists, it gets summarily rejected. And, as always, the next time will be different. The reality we are dealing with is that the FDA never approves this product. We have no idea why.
You ass! That statement is what EVERY company has to put in their pressers when going for an approval. Just standard legal jargon! God you’re an idiot!
WTF has been going on since 2017 with PMA bullshit? Epic morons, as you call them, should consider and understand this. I have not seen one bit of evidence suggesting anything has ever changed since then. Does anyone care to explain what has been going on since 2017 that will garner FDA approval (besides the fraud the SEC uncovered which seems to be the only activity)?
There will be no failure. Only epic morons think this. Surgicrap is a total disgrace which was never approved by the FDA and was grandfathered in and has so many side effects that they’ve had multiple lawsuits against it. The FDA has been carrying us to the finish line, which I finally realized. They could’ve reset the clock on us 10 to 20 times but they never did because they realize Surgicrap is an embarrassment and they want that product out of there.
blob:https://tdameritrade-researchcomponents.markitdigital.com/2299eaf2-28ad-4456-88e2-9dafaca75d60\
The annual report was posted.
Why doesn't Thom want his clients to know he is CEO of a stock scam? He does not list it on his write up with Waveny Partners.
https://www.butlercap.com/our-team-2
Meanwhile the CEO is employed at Butler Capital on the other side of the country:
https://brokercheck.finra.org/individual/summary/4231884
Does he do anything more than manipulate the unrealistically high price of this stock scam?
https://www.butlercap.com/our-team-2
Confirmation of UHP headquarters: UHP headquarters map and photo
https://uhpcorp.com/contact-us/
Stop by and get a u-haul in the desert instead of bandages?
Yes 1 Billion'$+ is my starting offer from the big pharms! Looking for RCA to make Brian Thoms some recommendations for a buyout plan!
https://www.rcainc.com/pharmaceutical/strategic-consulting/due-diligence-pharmaceutical-consulting-firm/
$5-$10+
More groundless and unsubstantiated bullshit from rodman.
Sure you are. Amazing how many first time posters have shown up lately. How telling when you refer to facts and links from reputable sources like the SEC as noise.
"How does that work, how does UEEC get on everyone's radar assuming they get the PMA?" Good question?
JMO but third party consultants like RCA do not stop servicing clients upon the FDA submission. No they network with the intention of furthering their business and profits. For example RCA is reaching out to others soon with their pharmaceutical events where the big money may yet be made for UEEC and investors! (Shareholders) The party is just starting so jump in now at this ridiculous low pps.
https://www.rcainc.com/cphi-north-america/
$5-$10+
I'm long and first time poster. According to what I'm reading, everyone is now using the eStar program since 10/1/2023. Does this seem correct?
https://www.fda.gov/medical-devices/premarket-notification-510k/510k-submission-process
This seems to be the only active board on UEEC with anything insightful posted, as long as you filter out the noise. As long as we go north of $0.70/share then I'll finally be in the black. I'm riding this lotto ticket all the way to the finish line, be it a big payout or total loss. Not gonna make Tuscan villa money, but definitely luxury car money if it runs up.
Even if we get the PMA approval, I'm concerned that none of the big players know we exist. How does that work, how does UEEC get on everyone's radar assuming they get the PMA? Or is just getting it enough, and it's publicly noticed by the FDA and the interested acquiring parties show up at the door?
Getting old; wasn't there commentary that FDA was going to fast track this application as one of the early tests for the E Star application program? Maybe one or two PR's ago? If so; a 90 day window might be in play?
The banter is quite entertaining. One the one side there is speculation that this is going to be a big week. On the other side, it's going to be a complete failure and all of us longs are going to lose $$$ bigtime.
Here's the reality. It's in the FDA hands. They have up to 180 days to respond. They can respond as slow or as fast as they like. Until we get official word, we won't know what reality is. Based on this, we will know sometime this year.
Until there is news, we can't expect this stock to do anything other than hover around $0.20
Hard to get excited about up and down with no sustained growth in $SP.
Selling volume concerning.
Big week ahead! Looking for an update!
$5-$10++
Guess we would all be angry if I was unemployed and making penny's posting lies!
What a joke they are.
$5-$10+
Yo Shoony!
Why are you so angry? Keep that pipe up for Facebook - it’s politics season. Go hang with your side and fight on ✌🏼
Or alternatively hit up One Love at the theater and Relax Brah
Life’s too short and my guess is yours is shorter so have some supper and take a nap.
There is no company to contact. The whole thing is a dirty broker run scam and so are you. Only an idiot would contact dirty brokers running a sham.
Who the eff are you bullshitting? A dirty broker threw $20 at the last minute to bullshit everyone. Dirty brokers are so desperate. They must have clients $$$$ tied up in this scam and trying desperately not to take heavy losses.
Who the eff are you bullshitting? Throw $20 at the last minute to bullshit everyone corrupt clown. You jackasses are so desperate. Do you dirty brokers have your clients $$$$ tied up in this scam and trying not to take heavy losses?
Looks like another nice Green Day !!
UEEC— On the verge of becoming a major player in the billion dollar surgical/triage arena. Major upside coming to UEEC.
Yep. I think when they are approved things will conclude quickly.
We haven't seen anything yet! With the FDA approval the big pharms interest in the gel application of hemostyp will increase. How about
an announcement for a clinical trial using United Health Products Hemostyp Gel underway!
$5-$10+
You're just embarrassing yourself pretending this isn't a scam that hoodwinks gullible suckers.
You had full FDA submission in 2017...what's changed?
https://www.otcmarkets.com/filing/html?id=12414685&guid=4td-kaJ6H_M4B3h#UEEC_EX991_HTM
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |